Instructions for Gaviscon Fortу for pregnant (Sodium alginate, bicarbonate, calcium carbonate) mint
Gaviscon Fortу for pregnant (Sodium alginate, bicarbonate, calcium carbonate) mint
English product name
Gaviscon Forte
Release form
usp. d/ingestion (in pregnancy, mint) 1000 mg+200 mg/10 ml: park. 12 pcs
Description Gaviscon:
The suspension is viscous, almost white to light brown, with a mint smell.
10ml
alginate sodium 1000 mg
potassium hydrogen carbonate 200 mg
Auxiliary substances:
calcium carbonate - 200 mg,
carbomer - 40 mg, methylparahydroxybenzoate - 40 mg,
propyl parahydroxybenzoate - 6 mg,
sodium hydroxide - 14.44 mg,
sodium saccharinate - 10 mg,
mint flavor - 6 mg, water purified - up to 10 ml.
10 ml - multilayer bags (12) - cardboard packs.
ATC codes
A02BX Other anti-ulcer drugs
Clinical-pharmacological groups / Group affiliation
Antacid preparation
Active substance Gaviscon
potassium hydrogen carbonate
alginate sodium
Pharmacotherapy group Gaviscon:
Antacid agent
Release form
for oral administration (mint) 1000 mg+200 mg/10 ml: fl 150 ml
Suspension description:
The infusion suspension (mint) is viscous, from almost white to light brown, with a mint smell.
10ml
alginate sodium 1000 mg
potassium hydrogen carbonate 200 mg
Auxiliary substances:
calcium carbonate - 200 mg,
carbomer - 40 mg,
methylparahydroxybenzoate - 40 mg,
propyl parahydroxybenzoate - 6 mg,
sodium hydroxide - 14.44 mg,
sodium saccharinate - 10 mg,
mint flavor - 6 mg,
water purified - up to 10 ml.
150 ml - bottles of dark glass with the control of the first opening.
ATC codes
A02BX Other anti-ulcer drugs
Testimony Gaviscon:
- Symptomatic treatment of dyspepsia associated with acidity of gastric juice and gastroesophageal reflux
- (heartburn, acid burp),
- feeling of heaviness in the stomach after eating,
- including pregnancy.
Method of use, course and dosage:
Inwards, according to the individual pattern, depending on the dosage form.
Do not use the tool for a long time. If symptoms persist after 7 days, the patient should consult a doctor.
Application in elderly patients
No dose correction is required for elderly patients.
Use in children
The use of the agent in children under the age of 12 years is contraindicated.
- Nosology Gaviscon (ICD codes)
- K21
- Gastroesophageal reflux
- K30
- Functional dyspepsia (digestive disorder)
- O99.6
- Digestive diseases complicating pregnancy, childbirth and the postpartum period
- R12
- Izzhoga
- R14
- Flatulence and related states (including bloating, burping)
Pharmacological effect Gaviscon:
After ingestion, the agents quickly interact with the acidic contents of the stomach. This forms an alginate gel with a pH value close to neutral. The gel forms a protective sheath on the surface of the stomach contents, preventing the appearance of gastroesophageal reflux for up to 4 hours.
In severe cases (with regurgitation), the gel enters the esophagus faster than the rest of the gastric contents, where it reduces mucous membrane irritation.
A reduction in irritation is felt three to four minutes after the ingestion of the
